Baxter International Inc. (NYSE:BAX) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for extension ...
“ With today’s CHMP recommendation, Baxter looks forward to offering patients suffering from MMN a licensed treatment option to relieve their symptoms of limb weakness and motor dysfunction,” said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results